RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 125 filers reported holding RA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,260,000 | +59.1% | 26,247 | +55.5% | 0.00% | 0.0% |
| Q4 2019 | $792,000 | -37.7% | 16,884 | -68.6% | 0.00% | 0.0% |
| Q3 2019 | $1,272,000 | -25.3% | 53,773 | -5.0% | 0.00% | 0.0% |
| Q2 2019 | $1,703,000 | +42.7% | 56,619 | +6.3% | 0.00% | 0.0% |
| Q1 2019 | $1,193,000 | +390.9% | 53,267 | +298.4% | 0.00% | – |
| Q4 2018 | $243,000 | +19.7% | 13,369 | +19.1% | 0.00% | – |
| Q3 2018 | $203,000 | +244.1% | 11,224 | +1.7% | 0.00% | – |
| Q1 2018 | $59,000 | – | 11,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |